The majority of patients had invasive ductal carcinoma as a histologic tumor type, regardless of ER/PR/HER2 subtype (163/232 = 70%), followed by invasive lobular carcinoma (34/232 = 14.6%). This evidence concerns the gene ERBB2 and invasive ductal breast carcinoma.